AIG
TGTX icon

American International Group’s TG Therapeutics TGTX Stock Holding History

American International Group’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-68,341
Closed -$1.04M – 2455
2024
Q1 		$1.04M Sell
68,341
-587
-0.9% -$9.35K ﹤0.01% 1274
2023
Q4 		$1.18M Buy
68,928
+446
+0.7% +$5.18K ﹤0.01% 1216
2023
Q3 		$573K Buy
68,482
+2,435
+4% +$33.9K ﹤0.01% 1531
2023
Q2 		$1.64M Buy
66,047
+1,759
+3% +$45.4K 0.01% 1023
2023
Q1 		$967K Buy
64,288
+1,279
+2% +$19.4K 0.01% 1232
2022
Q4 		$745K Sell
63,009
-229
-0.4% -$1.66K 0.01% 1365
2022
Q3 		$374K Buy
63,238
+893
+1% +$5.86K ﹤0.01% 1760
2022
Q2 		$265K Sell
62,345
-1,962
-3% -$12.3K ﹤0.01% 1998
2022
Q1 		$612K Sell
64,307
-4,527
-7% -$52.4K ﹤0.01% 1613
2021
Q4 		$1.31M Sell
68,834
-1,327
-2% -$34.5K 0.01% 1264
2021
Q3 		$2.33M Sell
70,161
-1,667
-2% -$51.6K 0.01% 1003
2021
Q2 		$2.79K Sell
71,828
-2,247
-3% -$88.2K 0.01% 986
2021
Q1 		$3.57K Buy
74,075
+3,469
+5% +$167K 0.01% 918
2020
Q4 		$3.67K Buy
70,606
+4,206
+6% +$142K 0.01% 886
2020
Q3 		$1.78M Buy
66,400
+7,329
+12% +$169K 0.01% 998
2020
Q2 		$1.15M Buy
59,071
+8,057
+16% +$130K 0.01% 1152
2020
Q1 		$502K Sell
51,014
-2,947
-5% -$37.2K ﹤0.01% 1437
2019
Q4 		$599K Buy
53,961
+2,171
+4% +$16.5K ﹤0.01% 1596
2019
Q3 		$291K Buy
51,790
+1,799
+4% +$12.5K ﹤0.01% 1956
2019
Q2 		$432K Buy
49,991
+9,940
+25% +$75.1K ﹤0.01% 1779
2019
Q1 		$322K Sell
40,051
-1,299
-3% -$7.02K ﹤0.01% 1950
2018
Q4 		$170K Sell
41,350
-317
-0.8% -$1.57K ﹤0.01% 2277
2018
Q3 		$233K Buy
41,667
+3,126
+8% +$35.7K ﹤0.01% 2336
2018
Q2 		$507K Buy
38,541
+5,718
+17% +$78.6K ﹤0.01% 1832
2018
Q1 		$466K Sell
32,823
-1,765
-5% -$22.6K ﹤0.01% 1762
2017
Q4 		$284K Buy
34,588
+2,053
+6% +$17.9K ﹤0.01% 2103
2017
Q3 		$386K Buy
32,535
+2,433
+8% +$27.7K ﹤0.01% 1909
2017
Q2 		$303K Buy
30,102
+7,421
+33% +$83.1K ﹤0.01% 2018
2017
Q1 		$264K Buy
22,681
+1,500
+7% +$10.8K ﹤0.01% 2006
2016
Q4 		$98K Sell
21,181
-55
-0.3% -$323 ﹤0.01% 2619
2016
Q3 		$164K Buy
21,236
+32
+0.2% +$206 ﹤0.01% 2298
2016
Q2 		$128K Sell
21,204
-1,112
-5% -$9.04K ﹤0.01% 2425
2016
Q1 		$190K Hold
22,316
– – ﹤0.01% 2838
2015
Q4 		$266K Sell
22,316
-36
-0.2% -$455 ﹤0.01% 2550
2015
Q3 		$225K Buy
22,352
+24
+0.1% +$358 ﹤0.01% 2703
2015
Q2 		$370K Buy
22,328
+4,462
+25% +$70.7K ﹤0.01% 2451
2015
Q1 		$277K Hold
17,866
– – ﹤0.01% 2683
2014
Q4 		$283K Buy
17,866
+1,904
+12% +$24.8K ﹤0.01% 2648
2014
Q3 		$170K Buy
15,962
+604
+4% +$5.6K ﹤0.01% 3096
2014
Q2 		$144K Buy
15,358
+4,791
+45% +$30.6K ﹤0.01% 3282
2014
Q1 		$72.9K Buy
10,567
+254
+2% +$1.5K ﹤0.01% 3658
2013
Q4 		$40.2K Buy
10,313
+1,750
+20% +$7.07K ﹤0.01% 3862
2013
Q3 		$43.6K Buy
+8,563
New +$52.4K ﹤0.01% 3788

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American International Group's TGTX Position: Q2 2024 in Review

American International Group sold out of TG Therapeutics (TGTX) in Q2 2024, closing a stake of 68,341 shares — an estimated $1.04M sold.

American International Group first reported a position in TGTX in Q3 2013 and held it in 43 quarters. The position peaked at $2.33M in Q3 2021. 259 funds tracked by Wall St. Rank hold TGTX as of Q2 2024.

  • American International Group reported no remaining TG Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 68,341 TG Therapeutics shares in Q2 2024, an estimated $1.04M.
  • American International Group first reported a position in TG Therapeutics in Q3 2013 and held it in 43 quarters.
  • American International Group's TG Therapeutics position peaked at $2.33M in Q3 2021.
  • 259 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.